Back to results
US 2022/0023220 A1Published application
Rapidly disintegrating oral tablet
AssigneeColumbia Care LLC
InventorsAaron M. Dely, Shaun Ben-Ari
Life of this patent
Estimating the term…
Abstract
Disclosed are cannabinoid formulations and methods of use associated therewith. Specifically, disclosed are rapidly disintegrating or dissolving tablets for oral administration comprising one or more cannabinoids or cannabinoid extracts.
Claims42
A formulation comprising:
- a. at least one cannabinoid or a derivative thereof,
- b. a solvent, and
- c. a pharmaceutically acceptable adsorbent.
A formulation comprising:
- a. CBD and THC cannabinoid extract,
- b. coconut oil,
- c. microcrystalline cellulose,
- d. mannitol,
- e. sodium starch glycolate,
- f. silicon dioxide,
- g. magnesium stearate, and
- h. a flavor.
5 more elements
Dependencies are inferred from the claim text.